Qiagen

company

QIA Frankfurt SE · home listing QGEN NYSE ISIN NL0000240000 SEC CIK 1015820 LEI 54930036WK3GMCN17Z57
Follow Qiagen Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · US GAAP
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$1B$0$1B$2B$3BFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$2.1B$437M
FY24$2B$59.8M
FY23$2B$484.8M
FY22$2.1B$575.7M
FY21$2.3B$537.1M
FY20$1.9B$73.6M
FY19$1.5B−$69.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20%0%20%40%60%80%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2561.9%22.4%20.9%
FY2448.6%5.9%3%
FY2362.5%21%24.7%
FY2264.2%24.9%26.9%
FY2164.2%28.2%23.9%
FY2065.6%20.5%3.9%
FY1965.4%−3.3%−4.6%
Free cash flowOperating cash flow minus capital expenditure
$0$200M$400M$600M$800MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$615.2M
FY24$639.8M
FY23$451.4M
FY22$694.8M
FY21$537.4M
FY20$412.4M
FY19$306.4M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$25M$50M$75M$100MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearDividendsBuybacks
FY25$54.2M-
FY24--
FY23--
FY22-$0
FY21-$100M
FY20-$64M
FY19-$74.5M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Qiagen
  • Healthcare median
−100%−50%0%50%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearQiagenHealthcare median
FY2520.9%−30.6%
FY243%−47%
FY2324.7%−58%
FY2226.9%−80.4%
FY2123.9%−71.9%
FY203.9%−62.2%
FY19−4.6%−46.3%